Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Minimum Effective Dose”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01059318
What this trial is testing

Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
Novartis Pharmaceuticals 24
Large-scale testing (Phase 3)Ended earlyNCT00295776
What this trial is testing

Lamictal in the Treatment of Post-Herpetic Neuralgia

Who this might be right for
Neuralgia, Postherpetic
George Washington University
Large-scale testing (Phase 3)UnknownNCT03298698
What this trial is testing

Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic SyndromeMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Radboud University Medical Center 40
Post-approval studies (Phase 4)Study completedNCT06587386
What this trial is testing

The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function

Who this might be right for
Motion Sickness
Affiliated Hospital of Jiaxing University 55
Large-scale testing (Phase 3)UnknownNCT01087242
What this trial is testing

Clinical Trail of Tang-min-Ling Pills in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 480
Testing effectiveness (Phase 2)Active Not RecruitingNCT06852963
What this trial is testing

A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001

Who this might be right for
Retinitis Pigmentosa 11Retinal DegenerationRetinal Disease+2 more
PYC Therapeutics 17
Not applicableStudy completedNCT00716755
What this trial is testing

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Centre for Addiction and Mental Health 45
Large-scale testing (Phase 3)Ended earlyNCT03711162
What this trial is testing

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

Who this might be right for
Idiopathic Pulmonary Fibrosis
Lakefront Biotherapeutics NV 525
Not applicableLooking for participantsNCT07338916
What this trial is testing

Dose-Finding Study: MEV90 for Local Anesthetic in Interscalene Block for Supraclavicular Nerves Block

Who this might be right for
Brachial Plexus BlockadeShoulder SurgerySuperficial Cervical Plexus Block
Hospital del Trabajador de Santiago 55
Testing effectiveness (Phase 2)Study completedNCT01620554
What this trial is testing

Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)

Who this might be right for
Obstructive Sleep ApnoeaExcessive Daytime Sleepiness
Bioprojet 110
Testing effectiveness (Phase 2)Study completedNCT03345485
What this trial is testing

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Who this might be right for
Small Cell Lung CancerSoft Tissue SarcomaTriple-negative Breast Cancer+2 more
Mundipharma Research Limited 71
Post-approval studies (Phase 4)WithdrawnNCT02893995
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics
Large-scale testing (Phase 3)Study completedNCT00306722
What this trial is testing

An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy

Who this might be right for
BronchoscopyAnesthesia
Eisai Inc. 250
Testing effectiveness (Phase 2)Study completedNCT00213239
What this trial is testing

A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children

Who this might be right for
Hematologic DiseasesNeoplasms
The Hospital for Sick Children 64
Testing effectiveness (Phase 2)Study completedNCT00612014
What this trial is testing

Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis

Who this might be right for
GastroparesisDiabetes Mellitus
Tranzyme, Inc. 78
Not applicableStudy completedNCT03899038
What this trial is testing

Minimum Effective Dose of 0.5% Bupivacaine for Ultrasound-guided Spinal Anesthesia Using Taylor's Approach

Who this might be right for
Lower Limb Surgery
Huazhong University of Science and Technology 56
Post-approval studies (Phase 4)Study completedNCT00904709
What this trial is testing

The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders

Who this might be right for
Menorrhagia
K. Sue Robinson 249
Post-approval studies (Phase 4)Study completedNCT01577472
What this trial is testing

Efficacy Study Comparing the Effect of Clomiphencitrate to an Antagonist Protocol

Who this might be right for
Female InfertilityOvarian Insufficiency
University Hospital, Basel, Switzerland 117
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Large-scale testing (Phase 3)Study completedNCT03512197
What this trial is testing

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals 511
Next Page